Else Nutrition Holdings Inc stock remains unchanged this week, with no major news impacting its performance.
Else Nutrition Holdings Inc (BABY.TO) has seen no movement in its stock price this week, closing at C$0.02. The company has been in the spotlight recently due to various operational updates, but as of now, there are no new developments affecting the stock directly. Investors may be keeping a close eye on the company's ongoing transformation efforts and its expansion into the adult nutrition market.
Advertisement
Else Nutrition Holdings Inc
BABY.TO
BABY.TO
Else Nutrition Holdings Inc
WealthAwesomeAdvertisement
Market cap
$1.15M
52W high
$0.25
52W low
$0.01
1W change
+0.00%
Beta
0.97
Analyst Price Targets
Based on analyst covering BABY
Wall Street analysts forecast BABY stock price to rise 24900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.00
+24900.0% Upside
Current Price
C$0.02
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BABY's historical volatility
30-Day Vol
183.7%
Annualized
90-Day Vol
178.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 – C$0.04 |
| 60 trading days | C$0.02 | C$0.01 – C$0.04 |
| 90 trading days | C$0.02 | C$0.01 – C$0.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: With a year-to-date decline of 80%, investors should consider the operational updates and financial results reported by Else Nutrition as they assess the company's potential for recovery and growth in the competitive consumer staples sector.
80% Year-to-Date Decline
Else Nutrition's stock has dropped 80% this year, highlighting the challenges the company faces even as it reports operational improvements.
Bull case
The recent operational turnaround and entry into the adult nutrition market could provide a boost for Else Nutrition. This shift may signal a potential rebound in performance as the company works towards becoming profitable.
Bear case
Despite the positive operational developments, the significant year-to-date decline and ongoing financial challenges raise concerns about the company's ability to sustain growth in the near term.
Price Action Overview
Advertisement
Else Nutrition Holdings Inc (BABY.TO) closed at C$0.02, with no change in price over the past week. The stock has seen a significant decline of 80% year-to-date, indicating ongoing challenges in the market.
Recent Company News
While there have been no major news releases this week, Else Nutrition has recently reported various operational improvements and financial results for fiscal year 2025. These include a significant operational turnaround in Q3 2025, with improvements in gross margins and cost reductions. The company's expansion into the adult nutrition market with new plant-based products also marks a strategic move that could enhance its market position.
Technical Picture
From a technical standpoint, Else Nutrition's stock is trading below its 50-day moving average of C$0.03, which is a decline of 29.1%. The 200-day moving average stands at C$0.09, reflecting a substantial 78.8% drop from the current price. The stock has a beta of 0.97, indicating it moves in line with the market. The recent trading volume of 252,592 shares is 1.49 times the 20-day average volume of 169,200 shares, suggesting increased investor interest despite the lack of price movement.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
